Company: ADPT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0000950170-25-103120
Chunk: 1

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Item 1
Chunk 1
---
 current portion

     74,413

     79,148

     Deferred revenue, less current portion

     20,032

     27,256

     Revenue interest liability, net, less current portion

     130,495

     132,414

     Other long-term liabilities

     20

     20

     Total liabilities

     317,101

     336,891

     Commitments and contingencies (Note 9)

     Shareholders’ equity

     Preferred stock: $0.0001 par value, 10,000,000 shares authorized at June 30, 2025 and December 31, 2024; no shares issued and outstanding at June 30, 2025 and December 31, 2024

     —

     —

     Common stock: $0.0001 par value, 340,000,000 shares authorized at June 30, 2025 and December 31, 2024; 152,234,772 and 147,773,744 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively

     15

     14

     Additional paid-in capital

     1,538,919

     1,506,353

     Accumulated other comprehensive gain

     73

     166

     Accumulated deficit

     (1,359,290
     )

     (1,303,824
     )

     Total Adaptive Biotechnologies Corporation shareholders’ equity

     179,717

     202,709

     Noncontrolling interest

     (181
     )

     (224
     )

     Total shareholders’ equity

     179,536

     202,485

     Total liabilities and shareholders’ equity
      
     $
     496,637

     $
     539,376

The accompanying notes are an integral part of these condensed consolidated financial statements.